Posted by Michael Wonder on 17 Feb 2022
COVID-19 vaccine weekly safety report (17 February 2022)
17 February 2022 - To 13 February 2022, the TGA has received 449 reports which have been assessed as likely to be myocarditis from about 35.2 million doses of Comirnaty (Pfizer) and 54 reports which have been assessed as likely to be myocarditis from about 3.4 million doses of Spikevax (Moderna).
No new cases of vaccine-related thrombosis with thrombocytopenia syndrome have been reported this year.
